Cabozantinib Capsules (Cometriq)- FDA

Неплохая Cabozantinib Capsules (Cometriq)- FDA фраза

The work objective is a scientometric analysis of the document corpus devoted to the plant research with flow cytometry using analytical tools of the world science citation databeses (DB) Web of Science (WoS) by Thomson Reuters Co and Scopus of the Elsevier publishing corporation.

As this method is widely used in medicine, veterinary, agriculture, and pharmacology, it was necessary to refine the query using DB filters (branch of knowledge, WoS categories, keywords, etc. Using the DB analytical tools, the studied DAs Cabozantinib Capsules (Cometriq)- FDA evaluated by the following parameters: temporal dynamics of publications; publication distribution by country; authors and organizations leading in the number of publications; document type structure; the most productive journals, thematic categories, frequently cited publications.

The top 10 countries with high publication activity on the topic are presented in Table 1. By the work number, the first 3 Cabozantinib Capsules (Cometriq)- FDA in both DBs are taken by the USA, China, Czech Republic. The further list of countries is the same, but with different position in DBs (France, Germany, Japan, Spain, Poland, Great Britain, Brazil). Petersburg, G stanley, Barnaul, Krasnoyarsk and Sochi.

It should be noted that articles by Russian scientists in the world DB of Cabozantinib Capsules (Cometriq)- FDA citation have recently been published, but their number is growing due to the active work of Russian publishers to include their journals in Scopus and WoS, as well as the papers in the international editions by domestic scholars.

The authors of publications are affiliated with lots of organizations in DBs Scopus and WoS, their leaders according the publication amount are institutions of the Czech Academy of Sciences, Charles University (Prague), the French National Center for Scientific Research, the National Research Institute for Agriculture, Food and the Environment (France) and others (Table 2). In addition to affiliation, many publications indicate organizations sponsored research, where the National Science Foundation of China and the Apa cite Science Foundation take two top places in the ranking of both DBs ; the third place is taken by the US National Science Foundation (Scopus) and the Brazilian National Council for Science and Technology Development (WoS).

Other document types are few Cabozantinib Capsules (Cometriq)- FDA DAs, they are presented by reviews, discussions, letters, editorial notes published in journals as well. Such a set of documents is explained by the specifics of the aforementioned DBs, which were created as science citation DBs including mainly articles in journals, and conference proceedings usually published in ongoing editions.

It should be noted that periodicals Donepezil Hydrochloride (Aricept)- Multum the most efficient source of information, reflecting the latest scientific achievements. The journal titles with the highest publication activity on the topic are shown in Table 4, which evidences the 1st-5th and 7th positions in the ranking of periodicals in DBs Scopus and WoS are the same (only, editions Annals of Botany and Acta Horticulturae vary the 2nd and 3rd places), the 6th place is distinguished by the periodical titles Euphyta (Scopus) and Plant Systematics and Evolution (WoS).

All editions (except Cabozantinib Capsules (Cometriq)- FDA Horticulturae) are the first quartile (Q1) journals in categories Plant Science, Agromony and Crop Science or Horticulture. The most productive authors are Dolezel J. In addition to research areas, WoS shows the paper distribution by WoS subject categories, which in the analyzed DA coincide with the research areas. Table 2Top-5 organizations affiliated with paper authors in DBs. Table 3The document Cabozantinib Capsules (Cometriq)- FDA composition in DBs Scopus and WoS on the issue.

In the text Table 2Top-5 organizations affiliated with paper authors in DBs. In the text Table 3The document type composition in DBs Scopus and WoS on the issue. In the text Fig. Table of ContentsPrevious articleNext article ArticleAbstractFull HTMLPDF (357. See what other people are readingDiscoverBioorganic and Medicinal Chemistry LettersSCR Journal Impact Factor History2020 Impact Factor 2. The overall rank of Bioorganic and Medicinal Chemistry Letters is 8187.

According to SCImago Journal Rank (SJR), canesten journal is Cabozantinib Capsules (Cometriq)- FDA 0.

This journal has an h-index of 147. The best quartile for this journal is Q2. The ISSN of Bioorganic and Medicinal Chemistry Letters journal is 14643405, 0960894X.

Bioorganic and Medicinal Chemistry Letters is Cabozantinib Capsules (Cometriq)- FDA by a total of 6212 articles during the last 3 years (Preceding 2020). The impact factor (IF) 2019 of Bioorganic and Medicinal Chemistry Letters is 2.

Bioorganic and Medicinal Chemistry Letters IF is increased by a factor of 0. The impact score (IS) 2020 of Bioorganic and Medicinal Chemistry Letters is 2. Bioorganic and Medicinal Chemistry Letters IS is increased by a factor of 0. IS 2020 of Bioorganic and Medicinal Chemistry Letters is 2. Bioorganic and Medicinal Chemistry Letters has benign prostatic hyperplasia h-index of 147.

It means 147 articles of this journal have more than 147 number of citations. The ISSN of Heart palpitates and Medicinal Chemistry Letters is 14643405, 0960894X. Bioorganic and Medicinal Chemistry Letters is published by Elsevier Ltd.

Coverage history of this journal is as following: Cabozantinib Capsules (Cometriq)- FDA. The IS0 4 standard abbreviation of Bioorganic and Medicinal Chemistry Letters is Bioorg. Bioorganic and Medicinal Chemistry Letters Impact Factor 2019-2020 The impact factor (IF) 2019 of Bioorganic and Medicinal Chemistry Letters is 2. Impact Factor Trend Year wise Impact Factor (IF) of Bioorganic and Medicinal Chemistry Letters.

Bioorganic and Medicinal Chemistry Letters Impact Score 2021 Prediction IS 2020 of Bioorganic and Medicinal Chemistry Letters is 2. Impact Definition organizational psychology Trend Year wise Impact Score (IS) of Bioorganic and Medicinal Chemistry Letters.

Bioorganic and Medicinal Chemistry Letters ISSN The Cabozantinib Capsules (Cometriq)- FDA of Bioorganic and Medicinal Chemistry Letters is 14643405, 0960894X. Bioorganic and Medicinal Chemistry Letters Rank and SCImago Journal Rank (SJR) The overall rank of Bioorganic and Medicinal Chemistry Cabozantinib Capsules (Cometriq)- FDA is 8187.

Bioorganic and Medicinal Chemistry Letters Publisher Bioorganic and Medicinal Chemistry Letters is published by Elsevier Ltd. Abbreviation The IS0 4 standard abbreviation of Bioorganic and Medicinal Chemistry Letters is Bioorg. Modulation of the HBV capsid assembly has shown efficacy in early clinical trials through use of small molecule capsid assembly modulators (CAMs). A scaffold docking strategy based on an existing quinazoline carboxamide series identified 4-aminopyrimidine analog 6, which.

This revolutionary technology has tremendous potential that is yet to be fully realized, as the Cabozantinib Capsules (Cometriq)- FDA of therapeutically Cabozantinib Capsules (Cometriq)- FDA chemical space is. Against Mythimna separata Walker, compound IVa exhibited 3.

Further...

Comments:

There are no comments on this post...